Tissue-derived tumor growth inhibitors, methods of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61K 38/19 (2006.01) A61K 38/20 (2006.01)

Patent

CA 2145179

The present invention provides a method for inhibiting cytotoxic poisoning of normal cells in a subject which comprises administering to the subject an amount of a Transforming Growth Factor Beta effective to slow the growth of normal cells and thereby inhibit the cytotoxic poisoning of the normal cells in the subject. Typically, administration is topical and initiated prior to antineoplastic therapy such as radiation treatment or chemotherapy. The invention is particularly suited for pediatric patients.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tissue-derived tumor growth inhibitors, methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tissue-derived tumor growth inhibitors, methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue-derived tumor growth inhibitors, methods of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2013246

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.